Abstract

Motoneuron disease including amyotrophic lateral sclerosis may be due, at an early stage, to deficit in the extracellular clearance of the excitatory transmitter glutamate. A model of glutamate-mediated excitotoxic cell death based on pharmacological inhibition of its uptake was used to investigate how activation of neuronal nicotinic receptors by nicotine may protect motoneurons. Hypoglossal motoneurons (HMs) in neonatal rat brainstem slices were exposed to the glutamate uptake blocker DL-threo-β-benzyloxyaspartate (TBOA) that evoked large Ca2+ transients time locked among nearby HMs, whose number fell by about 30% 4 h later. As nicotine or the gap junction blocker carbenoxolone suppressed bursting, we studied connexin 36 (Cx36), which constitutes gap junctions in neurons and found it largely expressed by HMs. Cx36 was downregulated when nicotine or carbenoxolone was co-applied with TBOA. Expression of Cx36 was preferentially observed in cytosolic rather than membrane fractions after nicotine and TBOA, suggesting protein redistribution with no change in synthesis. Nicotine raised the expression of heat shock protein 70 (Hsp70), a protective factor that binds the apoptotic-inducing factor (AIF) whose nuclear translocation is a cause of cell death. TBOA increased intracellular AIF, an effect blocked by nicotine. These results indicate that activation of neuronal nicotinic receptors is an early tool for protecting motoneurons from excitotoxicity and that this process is carried out via the combined decrease in Cx36 activity, overexpression of Hsp70 and fall in AIF translocation. Thus, retarding or inhibiting HM death may be experimentally achieved by targeting one of these processes leading to motoneuron death.

Highlights

  • Amyotrophic lateral sclerosis (ALS) is characterized by motoneuron death in the brainstem and spinal cord

  • Nicotine or carbenoxolone significantly decreased the number of transients evoked by TBOA (Figure 1c; P = 0.001) as they fell from 4.4 ± 0.4 (n = 69 Hypoglossal motoneurons (HMs)) to 2.8 ± 0.2 (Po0.05, n = 40 HMs) in presence of nicotine, or to 2.3 ± 0.3 (Po0.05, n = 18 HMs) with carbenoxolone co-application

  • As mitochondrial dysfunction and motoneuron death are observed after 4-h treatment with TBOA,[13] we evaluated connexin 36 (Cx36) expression (Figures 3a and b; red) in relation to immunoreactivity of single HMs

Read more

Summary

Introduction

Amyotrophic lateral sclerosis (ALS) is characterized by motoneuron death in the brainstem and spinal cord. We recently observed that the neuronal acetylcholine receptor (nAChR) agonist nicotine prevents HM dysfunction and associated cell death.[13,14] these effects are dependent on nAChR activation,[13] it seems likely that nicotine was a trigger for intracellular and network events contrasting excitotoxicity Within this framework, on rat brainstem motoneurons nicotine induces early facilitation of glutamate release followed by depression together with enhancement of inhibitory neurotransmission.[20] As a result of the complexity of the brainstem circuitry and its afferent projections, it is likely that the result of nicotine activity is the outcome of interplay among a variety of mechanisms.

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call